BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10965903)

  • 1. Antidiabetic sulfonylurea enhances secretagogue-induced adrenocorticotropin secretion and proopiomelanocortin gene expression in vitro.
    Morishita M; Iwasaki Y; Yamamori E; Nomura A; Mutsuga N; Yoshida M; Asai M; Oiso Y; Saito H
    Endocrinology; 2000 Sep; 141(9):3313-8. PubMed ID: 10965903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
    Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
    J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells.
    Katahira M; Iwasaki Y; Aoki Y; Oiso Y; Saito H
    Endocrinology; 1998 May; 139(5):2414-22. PubMed ID: 9564853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovine anterior pituitary proopiomelanocortin gene expression is not increased by ACTH secretagogues in vitro.
    Levin N; Wallace C; Bengani N; Blum M; Farnworth P; Smith AI; Roberts JL
    Endocrinology; 1993 Apr; 132(4):1692-700. PubMed ID: 8384993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleukin-1 on proopiomelanocortin gene expression in rat anterior pituitary cells.
    Suda T; Tozawa F; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Yamada M; Demura H; Shizume K
    Endocrinology; 1989 Mar; 124(3):1444-9. PubMed ID: 2537181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein.
    Jin WD; Boutillier AL; Glucksman MJ; Salton SR; Loeffler JP; Roberts JL
    Mol Endocrinol; 1994 Oct; 8(10):1377-88. PubMed ID: 7854355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1923-9. PubMed ID: 9112388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cyclic AMP-mediated proopiomelanocortin gene promoter activity by calcium channel blockers in a pituitary cell line.
    Ikeda M; Kakuyama M; Shoda T; Iwasaki Y; Fukuda K
    Eur J Pharmacol; 2007 Mar; 558(1-3):1-6. PubMed ID: 17196958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of loperamide and other opioid-related substances on the transcriptional regulation of the rat pro-opiomelanocortin gene in AtT20 cells.
    Nomura A; Iwasaki Y; Aoki Y; Yamamori E; Mutsuga N; Yoshida M; Asai M; Oiso Y; Saito H
    Neuroendocrinology; 2001 Aug; 74(2):87-94. PubMed ID: 11474216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of proopiomelanocortin gene promoter activity by local anesthetics in a pituitary cell line.
    Ikeda M; Kakuyama M; Shoda T; Fukuda K
    Reg Anesth Pain Med; 2007; 32(1):60-6. PubMed ID: 17196494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
    Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
    Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of proopiomelanocortin gene expression in cultured pituitary cells by benzodiazepines.
    Fukuda K; Uetsuki N; Uga H; Hashiguchi M; Sato M; Hisano T; Segawa H; Iwasaki Y
    Anesthesiology; 2003 May; 98(5):1172-7. PubMed ID: 12717139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMP-activated protein kinase stimulates proopiomelanocortin gene transcription in AtT20 corticotroph cells.
    Iwasaki Y; Nishiyama M; Taguchi T; Kambayashi M; Asai M; Yoshida M; Nigawara T; Hashimoto K
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1899-905. PubMed ID: 17341551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells.
    Tsukamoto N; Otsuka F; Ogura-Ochi K; Inagaki K; Nakamura E; Toma K; Terasaka T; Iwasaki Y; Makino H
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):1-9. PubMed ID: 23701823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids.
    Gagner JP; Drouin J
    Mol Endocrinol; 1987 Oct; 1(10):677-82. PubMed ID: 2856398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells.
    Bilezikjian LM; Blount AL; Campen CA; Gonzalez-Manchon C; Vale W
    Mol Endocrinol; 1991 Oct; 5(10):1389-95. PubMed ID: 1663577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary.
    Levin N; Blum M; Roberts JL
    Endocrinology; 1989 Dec; 125(6):2957-66. PubMed ID: 2555132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of nuclear factor-kB and Nurr-1 in cytokine-induced transcription of proopiomelanocortin gene in AtT20 corticotroph cells.
    Takayasu S; Iwasaki Y; Nigawara T; Asai M; Yoshida M; Kageyama K; Suda T
    Neuroimmunomodulation; 2010; 17(2):88-96. PubMed ID: 19923853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
    Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
    Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.